Mandate

Vinge advises Irisity in connection with a directed new share issue

November 14, 2019 Capital Markets and Public M&A

Vinge is advising Irisity in connection with a directed new share issue of 4,094,000 shares whereby Irisity acquires approximately SEK 35 million.

A subscription price of SEK 8.55 has been determined through an accelerated book building procedure and constitutes a discount of approximately 7.1 per cent in comparison with the closing price of Irisity shares on Nasdaq First North on 13 November 2019. The issue proceeds, which are expected to be sufficient for Irisity to acquire a positive cashflow, are intended to strengthen the company’s financial stability and also be used to expand the organisation within the fields of research, development, marketing, sales and service. The resolution adopted by the board of directors concerning the new share issue is conditional upon the approval thereof at an extraordinary general meeting.

 

Vinge’s team mainly consisted of Anders StridJohanna Hamrefält and Lina André.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026